3 unknown, 2 not yet recruiting. 5 Phase 1.
By phase and status
Follow Baermed: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial
Secretome - Liver Cirrhosis | Phase 1 | Not yet recruiting | 54 | 2024-12-01 | 2024-10-08 |
Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Drug Resistant Epilepsy Single Center, Non-randomized, Phase I Clinical Trial
Secretome - Epilepsy, Drugs Resistant Epilepsy | Phase 1 | Not yet recruiting | 54 | 2024-12-01 | 2024-10-15 |
Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia)
Secretome injection, Vitamin B12 Injection - Dementia, Moderate Dementia | Phase 1 | Unknown | 54 | 2024-10-15 | 2024-10-09 |
Hepatocyte Matrix Implant Study Indonesia
Hepatocyte Matrix Implant - Liver Cirrhosis, Liver Insufficiency | Phase 1 | Unknown | 10 | 2011-04-01 | 2011-04-14 |
Hepatocyte Matrix Implant Study
Hepatocyte matrix implantation - Liver Disease, Liver Cirrhosis | Phase 1 | Unknown | 10 | 2009-07-01 | 2011-04-12 |
Conditions studied
Liver Cirrhosis (3) · Dementia (1) · Drug Resistant Epilepsy (1) · Epilepsy (1) · Hepatic Insufficiency (1) · Liver Diseases (1)
Interventions
Secretome (3) · Ursodeoxycholic Acid (1) · Vitamin B 12 (1)
Countries
Indonesia (4) · Switzerland (1)
Top investigators
Hans U Baer, Prof, MD (1)
Results publications
PMID 33123384